Verition Fund Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
+31,799
| New | +$2.37M | 0.01% | 1331 |
|
|
2025
Q1 | – | Sell |
-4,381
| Closed | -$342K | – | 2744 |
|
|
2024
Q4 | $342K | Buy |
4,381
+1,411
| +48% | +$110K | ﹤0.01% | 2079 |
|
|
2024
Q3 | $239K | Sell |
2,970
-3,415
| -53% | -$274K | ﹤0.01% | 2092 |
|
|
2024
Q2 | $528K | Buy |
6,385
+4,005
| +168% | +$331K | ﹤0.01% | 1437 |
|
|
2024
Q1 | $203K | Sell |
2,380
-290
| -11% | -$24.8K | ﹤0.01% | 1895 |
|
|
2023
Q4 | $228K | Buy |
2,670
+290
| +12% | +$24.8K | ﹤0.01% | 1520 |
|
|
2023
Q3 | $213K | Buy |
2,380
+26
| +1% | +$2.33K | ﹤0.01% | 1599 |
|
|
2023
Q2 | $200K | Sell |
2,354
-1,426
| -38% | -$121K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $313K | Buy |
+3,780
| New | +$313K | ﹤0.01% | 1374 |
|
|
2021
Q2 | – | Sell |
-7,436
| Closed | -$825K | – | 1853 |
|
|
2021
Q1 | $825K | Buy |
+7,436
| New | +$825K | 0.01% | 569 |
|
|
2020
Q1 | – | Sell |
-8,238
| Closed | -$947K | – | 695 |
|
|
2019
Q4 | $947K | Buy |
+8,238
| New | +$947K | 0.02% | 383 |
|
|
2018
Q4 | – | Sell |
-3,917
| Closed | -$449K | – | 923 |
|
|
2018
Q3 | $449K | Sell |
3,917
-12,198
| -76% | -$1.4M | 0.02% | 818 |
|
|
2018
Q2 | $1.45M | Buy |
+16,115
| New | +$1.45M | 0.09% | 255 |
|
|
2017
Q4 | – | Sell |
-5,738
| Closed | -$257K | – | 944 |
|
|
2017
Q3 | $257K | Sell |
5,738
-5,702
| -50% | -$255K | 0.02% | 886 |
|
|
2017
Q2 | $452K | Buy |
+11,440
| New | +$452K | 0.04% | 425 |
|
|
2017
Q1 | – | Sell |
-5,712
| Closed | -$230K | – | 1206 |
|
|
2016
Q4 | $230K | Buy |
+5,712
| New | +$230K | 0.02% | 892 |
|